Optiscan and Long Grove Forge Exclusive US Partnership to Advance Fluorescein Imaging Trials

• Exclusive five-year collaboration agreement between Optiscan and Long Grove Pharmaceuticals
• Joint development of new clinical applications for fluorescein sodium drug AK-FLOUR®
• Use of AK-FLOUR® with Optiscan’s InVue® device in US clinical trials starting with breast surgery
• Collaboration data to support US FDA regulatory submissions for Optiscan’s surgical imaging device